Eric Easom - 20 Oct 2022 Form 4 Insider Report for AN2 Therapeutics, Inc. (ANTX)

Role
Chief Executive Officer, Director
Signature
/s/ Lucy Day, Attorney-in-Fact for Eric Easom
Issuer symbol
ANTX
Transactions as of
20 Oct 2022
Net transactions value
-$349,912
Form type
4
Filing time
24 Oct 2022, 21:44:31 UTC
Previous filing
16 May 2022
Next filing
26 Oct 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ANTX Common Stock Sale $121,140 -7,262 -28% $16.68 18,889 20 Oct 2022 Direct F1
transaction ANTX Common Stock Sale $532 -31 -0.16% $17.15 18,858 20 Oct 2022 Direct F1
transaction ANTX Common Stock Sale $189,008 -11,601 -62% $16.29 7,257 21 Oct 2022 Direct F1
transaction ANTX Common Stock Sale $39,232 -2,350 -32% $16.69 4,907 21 Oct 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.